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A B S T R A C T
Objectives: The EUSCREEN study compares the cost-effectiveness of paediatric hearing screening programmes
and aims to develop a cost-effectiveness model for this purpose. Alongside and informed by the development of
the model, neonatal hearing screening (NHS) is implemented in Albania. We report on the first year.
Methods: An implementation plan was made addressing objectives, target population, screening protocol,
screener training, screening devices, care pathways and follow up. NHS started January 1st, 2018 in four ma-
ternity hospitals: two in Tirana, one in Pogradec and one in Kukës, representing both urban and rural areas. OAE-
OAE-aABR was used to screen well infants in maternity hospitals, whereas aABR-aABR was used in neonatal
intensive care units and in mountainous Kukës for all infants. Screeners’ uptake and attitudes towards screening
and quality of screening were assessed by distributing questionnaires and visiting the maternity hospitals. The
result of screening, diagnostics, follow up and entry into early intervention were registered in a database and
monitored.
Results: Screeners were keen to improve their skills in screening and considered NHS valuable for Albanian
health care. The number of “fail” outcomes after the first screen was high initially but decreased to less than 10%
after eight months. In 2018, 11,507 infants were born in the four participating maternity hospitals, 10,925
(94.9%) of whom were screened in the first step. For 486 infants the result of screening was not registered. For
the first screen, ten parents declined, eight infants died and one infant was discharged before screening could be
performed. In 1115 (10.2%) infants the test either could not be performed or the threshold was not reached; 361
(32,4%) of these did not attend the second screen. For the third screen 31 (34.4%) out of 90 did not attend.
Reasons given were: parents declined (124), lived too far from screening location (95), their infant died (11), had
other health issues (7), or was screened in private clinic (17), no reason given (138).
Conclusions: Implementation of NHS in Albania is feasible despite continuing challenges. Acceptance was high
for the first screen. However, 32.4% of 1115 infants did not attend the second screen, after a “fail” outcome for
the first test.
1. Introduction
The EUSCREEN study [1] compares the cost-effectiveness of pae-
diatric vision and hearing screening programmes and aims to develop a
cost-effectiveness model for this purpose. When completed, the model
can be used to assist introduction, modification or disinvestment of a
screening programme in a country or region, taking into account the
local circumstances such as professionals available to screen and ex-
isting screening pathways. Alongside the development of the model and
informed by its preliminary predictions, neonatal hearing screening
(NHS) is being implemented in Albania, where hearing screening is not
yet routinely performed. The implementation of NHS is being evaluated
in three provinces in Albania: Tirana, Pogradec and Kukës. Information
gathered by the implementation study will be used to validate and
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calibrate the model to improve its predictions.
Studies that report on implementation of NHS can be retrospective
[2–4] or prospective [5–12] cross-sectional studies. They mainly report
on the outcomes related to the screening programme, such as coverage,
referral rates and attendance rates. Only a few describe the actual im-
plementation process and describe their experiences with requisites and
barriers for implementation [8,9,12]. In most countries where NHS has
been implemented, most of the infants are born in maternity hospitals.
Acceptance of the first screen has been found to vary between 90.85%
(China [11]) and 99.8% (Singapore [8]) (Table 1), however, out of all
infants screened in the first screen, the percentage that was invited for a
second screen varied between 1.7% [7] and 14.3% [9], whereas non-
attendance for the second screen varied between 0.1% in France [2]
and 51.6% in Nigeria [9]. Out of all infants who attended the second
screen, between 10.75% [10] and 31.3% [2] received a “fail” outcome
(the test could not be performed or the threshold was not reached).
Between 4.6% [2] and 64.6% [5] did not attend diagnostic assessment.
The Joint Committee on Infant Hearing (2007, 2019) [13,14] de-
fined benchmarks to evaluate the implemented NHS programmes. They
recommend to cover 95% of eligible infants and to refer less than 4% of
infants to diagnostic assessment. They also recommend for an infant to
complete screening within the first month after birth, to complete di-
agnostic assessment within 3 months after birth and to initiate inter-
vention within 6 months after birth.
Albania has a population of 2.9 million inhabitants and an annual
birth rate of about 30,869 [15]. Assuming a prevalence between 1 and 3
per 1000 neonates [16–18], in Albania approximately 30–90 out of the
30,869 infants are born with a permanent sensorineural hearing im-
pairment (HI) of more than 40 dB HL. Without a screening programme,
hearing disorders usually are not detected or treated until infants are
one to three years old [19,20]. Delays in detection and treatment of
childhood hearing impairments have serious consequences for speech,
language, cognitive and socio-emotional development [21,22] which
can be prevented or significantly reduced by neonatal hearing
screening, timely diagnosis and effective early intervention.
Albania is one of the few European countries currently without es-
tablished NHS. White (2010) [23] reported that of the countries that
have an NHS programme, seven screened over 90% of neonates, nine
countries screened 25–89% of neonates and 46 countries screened less
than 25% of neonates. Sloot et al. (2015) [24] reported that 33 of 38
European countries had a nationwide NHS programme.
An Albanian-Italian study, conducted in 2003–2004 by Hatzopoulos
et al. (2007) [25] and an Italian study, conducted in 2009–2012 and
funded by MAGIS by Beqiri and Nika (2015) [26] previously studied
implementation of NHS in Albania. Hatzopoulos et al. (2007) [25] used
a screening programme with two examinations in which infants who
failed the first otoacoustic emission (OAE) screen performed in the
maternity hospital 2–3 days after birth, underwent a second OAE after
four weeks. Infants who failed the second OAE were asked to return a
third time after 4–6 weeks for diagnostic assessment using click-audi-
tory brainstem response (ABR). They screened 463 well babies (WB;
healthy infants without any overt diseases) and 1098 infants admitted
to the neonatal intensive care unit (NICU). The programme had an at-
tendance of 98,5% for the initial OAE. However, 40–50% of infants did
not attend the second OAE. Two (0.18%) NICU infants of the 1098 and
none of the 463 WB were diagnosed with a bilateral hearing impair-
ment. Beqiri and Nika (2015) [26] screened 47,341 infants in the three
main cities of Albania (Tirana, Shkodra and Fier) with an OAE-ABR
protocol for WB and a single ABR for NICU infants. Of the infants
screened, 93 had a bilateral hearing impairment. These NHS pro-
grammes were not continued. At the time the studies ended, the Al-
banian government and its Ministry of Health did not consider con-
tinuation of NHS to be a priority, resulting in no programme
implementation at that time.
We report on the first year of implementation of a NHS programme
as part of the EUSCREEN project in three provinces in Albania (Tirana,
Pogradec and Kukës) that started on January 1st, 2018.
2. Methods
In what follows, we describe the prediction of the cost-effectiveness
model, the demography, the screening protocol and methods to assess
outcome of implementation.
2.1. Prediction of the cost-effectiveness model for Albania
A micro-simulation model has been developed using the
MIcrosimulation SCreening ANalysis (MISCAN) model structure [27].
This model was originally developed to simulate the natural history of
diseases and to evaluate screening programmes such as for cancer. It
was provisionally adapted to evaluate neonatal hearing screening pro-
grammes.
In the preparation phase in 2017, the cost-effectiveness model was
used to evaluate several possible NHS programme approaches, taking
into account local circumstances in Albania such as demography and
geography, natural history of hearing impairment in Albania and costs.
It proved to be impossible to make accurate predictions as the data
needed for the calculation were insufficient or unknown. Since the
model was still in the process of being developed, it was a challenge for
the preliminary version of the model to take all of the local circum-
stances into account to calculate the most cost-effective NHS pro-
gramme.
2.2. Demography
NHS was implemented in Tirana, Pogradec and Kukës in Albania
(Fig. 1) because they offer an appropriate representation of the general
population of Albania with respect to provision of health care in both
urban and rural areas and a range of socio-economic circumstances. The
NHS programme has been implemented in two maternity hospitals in
Tirana: Mbretëresha Geraldine (MG) and Koço Gliozheni (KG), each
having their own NICU department. It has also been implemented in the
Table 1
Studies on implementation of NHS in other countries, their protocol, attendance and referral rates.
Author Country Protocol Attendance screen 1 Invited screen 2 Non-attendance screen 2 Referral diagnostic assessment
Augustine, 2014 [5] India aABR, aABR 97.70% 9.10% 17.40%
Bouillot, 2019 [2] France aABR, aABR, (aABR) 99.50% 10.30% 0.10% 2.20%
Caluraud, 2015 [7] France OAE + aABR, aABR 99.40% 1.70% 7.90% 0.20%
Chen, 2017 [3] China OAE, OAE 93.60% 11.30% 31.30% 0.80%
Low, 2005 [8] Singapore OAE/aABR, OAE/aABR 99.80% 6.00%
Olusanya, 2008 [9] Nigeria OAE, aABR 14.30% 51.60% 4.10%
Saki, 2017 [10] Iran OAE + aABR, OAE + aABR 11.68% 4.23% 1.25%
Sun, 2009 [11] China OAE, OAE 90.85% 12.16% 34.32% 7.30%
Uilenburg, 2009 [12] The Netherlands OAE, OAE, aABR 94.00% 7.60% 6.30% 2.20%
Wood, 2015 [4] UK OAE + aABR 97.54% <3.00%
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maternity hospital in Pogradec and the maternity hospital in Kukës. The
maternity hospitals in Pogradec and Kukës provide limited NICU care.
In Albania the majority of the deliveries (> 97%) take place in a hos-
pital [28]. Deliveries at home are rare and occur mainly in remote
areas, where no adequate transport is available.
Whereas both Pogradec and Kukës are located in rural and moun-
tainous regions, Kukës is one of the poorest regions in Albania and the
inhabitants of the Kukës province are more spread out across the
countryside. Parents have to travel far from remote places to reach the
maternity hospital and roads are often blocked by snow in winter.
Pogradec is situated in the South-East of Albania near the border with
Macedonia and Kukës is situated near the border with Kosovo in the
North-East of Albania.
2.3. Location and timing of screening
The total number of births per year in the maternity hospitals in the
selected regions is approximately 11,500. The majority of deliveries
(approximately 10,000) take place in the two maternity hospitals in
Tirana. The maternity hospitals in Pogradec and Kukës each account for
400–600 births annually.
In Tirana and Kukës, mothers are discharged within 24 h after de-
livery. In Pogradec, discharge takes place within 48 h after delivery.
Unless infants are delivered by a caesarean section, mothers do not
return for routine follow up appointments after they have left the ma-
ternity hospital. To reach high coverage, the best option was to perform
the first screen in the period the mother and the infant were still in the
maternity hospital. However, when screening shortly after birth, re-
sidual amniotic fluid in the neonates’ middle ear has been shown to
cause a higher rate of failed tests [29,30]. OAE measures the reactive
sound emitted by the outer hair cells in the cochlea to a tone or click
produced by the screening device and played in the ear canal. The re-
sidual amniotic fluid causes the middle-ear to be less sound-conductive
and increases the number of “fail” outcomes during screening. Amniotic
fluid disappears when the middle ear is aeriated and more optimal
screening conditions may be reached between the third and fifth day
after birth [29]. An aABR detects the change in brain wave activity of
the auditory brainstem as a reaction to a tone or click. Screening tests
performed with aABR are less sensitive to transient conditions such as
amniotic fluid in the middle ear, which results in fewer false-positive
results [31].
Most existing NHS programmes commonly use a combination of
OAE and aABR in a screening protocol that consists of 2 or 3 subsequent
screening steps [24,32]. Sensitivity and specificity are between 90%
and 100% for both tests [33–35]. Although aABR is more sensitive and
specific, less sensitive to transient conditions in the middle and external
ear and more likely to detect auditory neuropathy, aABR may be more
expensive and time consuming than OAE. Both OAE and aABR can be
performed by a wide range of practitioners, provided that they are
appropriately trained and have gained sufficient experience.
The Ministry of Health was consulted by the local study coordinator
(BQ) to receive approval for the study and to decide on the maternity
hospitals that participate in the study. Agreements were made between
the Tirana University Hospital Centre (TUHC) and the maternity hos-
pitals in Tirana, Pogradec and Kukës. All infants born healthy as well as
all infants admitted to NICU in one of the four maternity hospitals were
eligible for NHS.
2.4. Screening personnel and training
The first screen was performed in the maternity hospital after de-
livery and before discharge. Nurses and midwives who were already
employed in the maternity hospitals were considered most suited to be
trained to perform the screening. Other NHS programmes have trained
a wide range of professionals for NHS such as health care professionals,
paediatricians, speech language therapists, audiologists or dedicated
screeners.
During the autumn of 2017 a training course of three days was set
up for screening nurses and midwives participating in the programme.
During the first course screeners were taught theoretical information
regarding anatomy and physiology of hearing, hearing impairment,
hearing (screening) tests, diagnostic assessment, factors influencing the
testing, etc. In the second course, screeners were taught about the
screening devices, and screeners were able to use the devices. In the last
course, screeners were taught about communication skills. They were
given information on how to approach and inform parents regarding
their participation in the screening programme, how screening can af-
fect the parents, how to explain the test they are performing, and how
to explain the result to the parents. After the course, the knowledge of
the participants was assessed by administering a test and their
Fig. 1. Map of Albania marked for Tirana, Pogradec and Kukës.
Map: Philippe Rekacewicz, Emmanuelle Bournay, UNEP/GRID-Arendal (http://
www.grida.no/resources/5360).
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screening skills were evaluated.
During screening the screeners were supervised by a team from the
University of Tirana supported by technical staff of the manufacturers.
After several months of screening a refresher course was organised so
screeners could exchange experiences, get help with problems identi-
fied and have questions answered.
An additional one-day course was set up for health care profes-
sionals from Tirana, Pogradec and Kukës that did not perform
screening: personnel (nurses and general practitioners (GP)) from
health centres in the villages, midwifes from maternity hospitals that
did not perform screening, paediatricians from child consultancy cen-
tres and public health workers. During this course these health care
professionals were informed about the purpose of the screening pro-
gramme, how screening is performed, how infants are followed up and
what kind of rehabilitation is provided. Furthermore, information on
NHS was included in the continuing education courses provided for
GP's nationwide. GP's will be informed on the screening outcome
through the ‘baby book’ each infant receives in the maternity hospital.
In this book, medical information such as birthweight is recorded, a
page was added to document the result of hearing screening.
2.5. Information for parents of screened children
The awareness of parents about the importance of early detection
and intervention and their acceptance of NHS is of great importance for
the success of the programme [36,37]. This has previously been re-
ported for NHS programmes in Albania [25,26]. Leaflets and posters
were developed to inform parents about hearing impairment and the
effect of hearing impairment on the development of their infants. One
leaflet was developed about the existence, rationale for and the course
of the screening programme. Another leaflet was developed about what
happens when an infant is referred for diagnostic assessment. In-
formation campaigns and interviews were broadcast on television and
radio. Furthermore, information videos were produced and played on
screens in the waiting rooms of the maternity hospitals.
2.6. Outcome criteria for implementation of the screening programme
In this ongoing implementation study, the following criteria for
implementation of screening are to be assessed: acceptability, adoption,
appropriateness, feasibility, fidelity, costs, coverage and sustainability
of the screening programme [38,39]. These criteria can only be assessed
after the implementation study has ended in 2020. The definitions and
appraisal methods of acceptability, adoption, appropriateness, feasi-
bility, fidelity, costs, coverage and sustainability of the screening pro-
gramme are presented in the supplemental material (Appendix 1).
A questionnaire was used to measure the screeners’ uptake and the
acceptability of hearing screening, their level of responsibility, and
their attitudes towards parents. It consisted of 155 multiple choice
questions in seven domains: general information, attitudes of the
screener towards hearing screening, hearing loss, parents of infants
screened and subcultures, individual features of the screener and ad-
ditional questions. This questionnaire was distributed amongst
screeners at the start of the screening programme and after one year of
screening. They will be asked to fill out the questionnaire again after
two years of screening. On-site visits and observations were made to
determine the adoption and adherence to the programme, to get an
indication of the commitment, understanding and the skills of the
screeners. The workflow in the maternity hospitals and the collabora-
tion within the screening teams in the maternity hospitals was studied:
how the teams experienced the training courses, how much they re-
membered after training, how well they used and handled the devices.
Additionally, interviews with 8 parents and all 21 nurses who perform
screening in each maternity were conducted. In these interviews, par-
ents were asked how they experienced the screening and what in-
formation they received. Nurses were asked about their experiences and
opinions regarding the screening programme.
At the end of the implementation study in 2020, the acceptability,
adoption, appropriateness, feasibility, fidelity, costs, coverage and
sustainability of the screening programme will be assessed.
2.7. Database of screened infants
To collect data about the screened infants, a database was devel-
oped for the implementation study. Data were filled out by local
screeners and the database was monitored by the Erasmus Medical
Centre in Rotterdam. All four maternity hospitals were assigned an
account in the database. Screeners were able to create their own ac-
count that was linked to one of the maternity hospitals. Each eligible
neonate was registered in the database by one of the screeners and was
assigned an anonymous and unique number. Screeners filled out med-
ical information about the neonates screened such as date of birth,
duration of the pregnancy and possible risk factors for hearing im-
pairment. They also registered the date and results of screening as well
as the reasons given by parents to decline screening. All three screening
outcomes were registered as well as subsequent diagnostics, follow up
and hearing-aid fitting. The overall coverage of the programme was
estimated from the number of eligible infants screened.
2.8. Care pathway and follow up strategies
Following referral from completion of screening, infants received
diagnostic assessment at the TUHC or Child Centre for Rehabilitation
(CCR) in Tirana. An audiometric booth was built in the TUHC. This
room was equipped with one diagnostic ABR device that can be used for
both diagnostic ABR and auditory steady state response testing.
Another diagnostic ABR device was installed in the CCR.
Because Albania had no formal neonatal hearing screening pro-
gramme to date, there was little experience with hearing aid fitting in
very young infants. In the spring of 2018, a team consisting of speech
language therapists, psychologists and paediatricians was trained to
help guide parents through the care pathway and provide early inter-
vention. This has helped to create a pathway for children with various
levels of hearing impairment and to ensure that the families experience
between detection of hearing impairment and appropriate follow up is
streamlined.
3. Results
3.1. Screening protocol
It had been our intention to have the model predict the best
screening protocol for the three provinces in Albania. However, the
development of the model had to be completed within 7 months and it
was not sufficiently finished when the decision on the protocol had to
be made and the training of screeners began. Furthermore, because of
the sparse and not very detailed data on demographics, current provi-
sion of health care, follow up and costs, it proved to be difficult to adapt
the model specifically for the situation in Albania and to make differ-
entiated regional predictions for Tirana, Pogradec and Kukës. For ex-
ample, because of the lack of experience with NHS, the margin of error
in the estimation of the costs for screening and diagnostic assessment
was very large. This information is difficult to collect, even in countries
with established NHS programmes.
As a consequence, decisions made for the screening programme
relied much on sound clinical judgement, experience of implementation
of NHS in other countries and conclusions made after the previous at-
tempts to implement NHS in Albania. Based on these considerations,
local circumstances, expected expenses associated with the screening
programme and expected costs for the parents a multi-step programme
including aABR was chosen to improve the specificity of the programme
and to reduce the number of infants that have to travel to Tirana for full
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diagnostic assessment. The sequence of the tests, the location, choice of
screening regime and postnatal age at the first screen and the age at
repeat screening were considered to be relevant to decide on the NHS
programme implemented in Tirana, Pogradec and Kukës. This led to the
use of a different protocol in the mountainous region of Kukës as this
could reduce the need for repeat screening in recognition of the long
journey parents have to undertake to reach the maternity hospital [40].
In anticipation of this problem, the number of steps were reduced and a
more specific screening test was expected to result in lower referral
rates.
The protocol for WB in Tirana and Pogradec was decided to be an
OAE-OAE-aABR test sequence. This protocol was used in both maternity
hospitals in Tirana and in the maternity hospital in Pogradec. This se-
quence was chosen because a three-step programme and the use of an
aABR screen offers high sensitivity and specificity. A two- or three-step
screening programme and a combination of both OAE and aABR are
commonly used across Europe, and higher sensitivity and specificity are
beneficial when high numbers of infants do not attend repeat screening.
In hindsight, more in-depth consideration about factors influencing low
attendance rates would have been advantageous.
For neonates admitted to NICU a sequence of aABR-aABR was
chosen to enable detection of auditory neuropathy. Neonates who had a
“fail” outcome after the final screen were referred to the ENT depart-
ment of the TUHC for diagnostic assessment.
To ensure maximum attendance and minimal costs for the first
screen, tests were performed in the maternity hospital immediately
before discharge. When a “fail” outcome was obtained for one or both
ears, a repeat screen was scheduled, after the result of the test was
explained to the parents. Within the current programme, infants who
lived outside Tirana were not tracked. When parents did not attend
repeat screening, they were contacted by the screeners by telephone.
When required, the second screen took place in the maternity hospital
approximately two weeks after the first screen and the third screen took
place in the maternity hospital approximately one week after the
second screen. As with WB, the first screen for NICU infants took place
before they left the maternity hospital. Parents who lived outside the
Tirana area were given the possibility to return for repeat screening in
Tirana, however, these parents were not actively reminded. These in-
fants may have been followed up elsewhere.
3.2. Screening location and devices
A room was prepared in all maternity hospitals exclusively for
hearing screening. A small bed for the neonates was installed as well as
screening devices with consumables and a computer with internet
connection to upload all screening data and fill out the case record form
in the database. Initial problems were that there was too much en-
vironmental noise and some screening rooms were too cold for the
neonates. No constructional acoustical improvements could be made in
any of the maternity hospitals. Therefore, a room was chosen in a
quieter part of the maternity hospital and measures were taken to im-
prove screening conditions. Broken doors and windows were replaced
to diminish environmental noise and electric heaters were installed to
make infants more comfortable during winter months.
Nine Natus Echo-Screen III devices were obtained to perform OAE
testing. These devices were distributed between the maternity hospitals
in Tirana and Pogradec and the university hospital. Six Interacoustics
Titan ABRIS devices to perform aABR testing were obtained for all
maternity hospitals. Equipment to perform these tests is calibrated and
validated regularly by the supplier to ensure sensitivity and specificity.
3.3. Screening personnel and training
Both teams in Tirana consisted of six screeners and an adminis-
trator. The local administrators were in charge of organising the
screening programme. They made sure sufficient consumables such as
probe tips and electrodes were available. Furthermore, the strategy
used to track all infants depended mainly on the local administrator
organising the follow up. In Pogradec, four nurses and one adminis-
trator took care of screening. The Kukës team consisted of four
screeners who alternated shifts to ensure there was always someone
present to perform the screening.
The screeners who participated in the project were payed approxi-
mately €150 per month by the study in addition to their salary,
€400–500 on average. Screening as well as administration took place in
overtime. All staff members selected to perform screening attended the
training courses and passed the assessment. Screeners were supervised
during the first screens and were only allowed to screen independently
after they became sufficiently skilful.
3.4. Information for parents of screened children
Before the screening test was done, parents were informed about
how the hearing screening test works and were able to ask questions
before giving written informed consent. After screening, the result was
explained. When the infant got a “fail” outcome for the screening test,
screeners made an appointment for the next screen one or two weeks
later in the maternity hospital.
Most parents were interested in participating in screening when
asked to participate in the maternity hospital. Only a few parents de-
clined screening based on their belief that their child could hear or that
the test might hurt their child. Screeners reported that the better par-
ents were informed about the project, the less they declined. This is
consistent with the wider literature [36,37].
3.5. On-site observations
Albania was visited four times by the authors (AB, HH, AG): during
the preparation phase, when screening had just started, a few months
after screening had started and after one year of screening.
Questionnaires were distributed to observe the implementation and to
determine the adoption of the programme. During the first two visits
and during the last visit all maternity hospitals were visited. During the
intermediate visit only the two maternity hospitals in Tirana were
visited. Screeners were interviewed. They expressed their ideas and
concerns about the programme. Only a few interviews with parents
were conducted, because the language barrier prevented an in-depth
conversation and translators were not always available. A follow up
visit will be made again after 24 months of screening.
During the first months of the screening programme, equipment
failures such as malfunctioning OAE devices and broken OAE probes
disturbed the screening process. The broken probes and devices were
sent back to the manufacturer for replacement but it took several weeks
for the equipment to be repaired. This did not delay screening since
back-up screening devices were available. Steps were taken to ensure
more care when handling the probes and transporting the devices.
Initially, it was difficult for the screeners to place the probe and
make sure all conditions were right for screening. Many tests were
paused and restarted when screeners experienced difficulties placing
the probe, when the probe fell out of the infants ear, the probe got
obstructed or when the infant was restless during the test. Initially “fail”
outcomes occurred often when screeners had not yet gained sufficient
experience in screening. These problems resulted in high failure rates
(50–80%) for the first screen. In Pogradec, 78% of infants were referred
for repeat screening in the first month. For most maternity hospitals the
failure rates for the first screen decreased to less than 10% after eight
months. The more neonates were being screened, the better the test
seemed to be executed and the lower the failure rate was (Fig. 2).
Differences were noted between the two maternity hospitals in
Tirana. The number of infants born in MB was 1.74 times higher than in
KG while the number of screeners was the same. This resulted in dif-
ferent outcomes. In KG, screening was organised in a more efficient way
A.M. Bussé, et al. International Journal of Pediatric Otorhinolaryngology 134 (2020) 110039
5
resulting in a lower referral rate and less infants not attending repeat
screening.
3.6. Screening outcome
All infants born in one of the four maternity hospitals involved in
the study were eligible for screening. In 2018, 9583 infants were born
in the Tirana province, 1634 in the Korçe province, in which Pogradec
is located, and 952 in the Kukës province [15]. In the participating
maternity hospitals, a total of 11,507 eligible infants were born. In
principal, all infants were invited to participate in screening. For
11,430 infants a record was made in de database but for 486 infants no
result of screening was registered. Out of the 10,944 remaining infants,
19 did not participate in the first screen because parents refused
screening (7), the infants died (8), or the infant was discharged before
screening could be performed (4). Out of all infants who participated in
the first screen, an additional 392 (3.4%) did not reach screen com-
pletion. Reasons given were: the infant died (21) or had other health
issues (8), parents were convinced their child could hear and did not
think repeat screening was necessary (9), parents went to a private
clinic for screening (17), parents lived too far away from the location
where screening took place and were unable to return (61), parents
declined screening but no further reason was given (157) or parents did
not attend without giving a reason (138). The distribution of reasons
given per maternity is shown in Table 2. In the first year, 97,28% of
infants completed screening within the first month after birth.
Of the 10,925 (94.9%) infants participating in the first screen, 1115
(10.2%) infants had a “fail” outcome. Six were referred to Tirana for
diagnostic assessment and all 1109 remaining infants were invited for
the second screen. Out of the 1109 infants invited, 361 (32.6%) did not
participate of whom 124 did not provide a reason. The remaining 748
(67.4%) were screened in the second screen, 90 (12%) of whom re-
ceived a “fail” outcome. Out of these 90 infants, ten were referred to
Tirana for diagnostic assessment and 31 did not participate in the third
screen, of which 14 did not provided a reason. Forty-nine infants par-
ticipated in the third screen. A total of 33 (0.30%) infants were referred
for full diagnostic assessment in Tirana (Fig. 3). The low referral rate in
general and the low referral rates for each screener were looked at in
more detail during the second year of screening. Results from the di-
agnostic assessment will be reported after the implementation study has
ended in December 2019.
Despite the use of a different protocol, the proportion of infants
referred in the Kukës maternity hospital was much higher than should
be anticipated [40]. This implies that further training may be needed.
This inconsistency has given rise to more in-depth exploration of the
situation in Kukës and what is required to maintain screener quality.
3.7. Assessment of screening implementation
Acceptability and adoption by the screeners were assessed by means
of the questionnaire. Nineteen of the twenty-one screeners returned a
Fig. 2. Pass rate of the first screen for each maternity hospital per month.
Ta
bl
e
2
Th
e
nu
m
be
r
of
in
fa
nt
s
sc
re
en
ed
in
th
e
fi
rs
t,
se
co
nd
an
d
th
ir
d
sc
re
en
in
fo
ur
m
at
er
ni
ty
ho
sp
it
al
s
in
A
lb
an
ia
.
Th
e
ta
bl
e
sh
ow
s
th
e
nu
m
be
r
of
“P
as
s”
an
d
“F
ai
l”
re
su
lt
s
pe
r
sc
re
en
,
th
e
nu
m
be
r
of
in
fa
nt
s
re
fe
rr
ed
fo
r
fu
ll
di
ag
no
st
ic
as
se
ss
m
en
t
an
d
th
e
nu
m
be
r
of
in
fa
nt
s
w
ho
di
d
no
t
at
te
nd
fo
llo
w
up
sc
re
en
in
g
in
cl
ud
in
g
th
e
re
as
on
s
gi
ve
n.
“F
ai
l”
re
su
lt
s
in
cl
ud
e
te
st
s
th
at
co
ul
d
no
t
be
pe
rf
or
m
ed
or
di
d
th
e
th
re
sh
ol
d
co
ul
d
no
t
be
re
ac
he
d.
M
br
et
ër
es
ha
G
er
al
di
ne
K
oç
o
G
lio
zh
en
i
Po
gr
ad
ec
K
uk
ës
Fi
rs
t
sc
re
en
Se
co
nd
sc
re
en
Th
ir
d
sc
re
en
Fi
rs
t
sc
re
en
Se
co
nd
sc
re
en
Th
ir
d
sc
re
en
Fi
rs
t
sc
re
en
Se
co
nd
sc
re
en
Th
ir
d
sc
re
en
Fi
rs
t
sc
re
en
Se
co
nd
sc
re
en
To
ta
l
66
15
58
4
32
37
95
35
3
40
44
2
11
8
8
57
8
54
U
nk
no
w
n
35
2
(5
.3
%
)
61
(1
.6
%
)
62
(1
4%
)
11
(1
.9
%
)
D
id
no
t
at
te
nd
14
(0
.2
%
)
27
0
(4
6.
2%
)
13
(4
0.
6%
)
5
(0
.1
%
)
57
(1
6.
1%
)
16
(4
0%
)
18
(1
5.
3%
)
2
(2
5%
)
16
(2
9.
6%
)
R
ea
so
n
U
nk
no
w
n
-
73
1
-
19
12
-
16
1
-
16
N
o
pa
re
nt
al
co
ns
en
t
5
11
7
7
5
18
2
-
2
1
-
-
In
fa
nt
liv
es
in
di
ff
er
en
t
ci
ty
1
40
1
-
17
2
-
-
-
-
-
In
fa
nt
sc
re
en
ed
in
pr
iv
at
e
ho
sp
ita
l
-
15
2
-
-
-
-
-
-
-
-
Pa
re
nt
s
co
nv
in
ce
d
in
fa
nt
ca
n
he
ar
-
6
1
-
2
-
-
-
-
-
-
In
fa
nt
di
ed
8
13
-
-
-
-
-
-
-
-
O
th
er
he
al
th
is
su
es
-
6
1
-
1
-
-
-
-
-
-
In
fa
nt
s
sc
re
en
ed
62
49
(9
4.
5%
)
31
4
(5
3.
8%
)
19
(5
9.
4%
)
37
29
(9
8.
3%
)
29
6
(8
3.
9%
)
24
(6
0%
)
38
0
(8
6%
)
10
0
(8
4.
7%
)
6
(7
5%
)
56
7
(9
8.
1%
)
38
(7
0.
4%
)
Pa
ss
56
63
(9
0.
6%
)
28
1
(8
9.
5%
)
14
(7
3.
7%
)
33
76
(9
0.
5%
)
24
8
(8
3.
8%
)
18
(7
5%
)
26
2
(6
8.
9%
)
91
(9
1%
)
50
9
(8
9.
8%
)
38
(1
00
%
)
Fa
il
58
4
(9
.3
%
)
32
(1
0.
2%
)
35
3
(9
.5
%
)
40
(1
3.
5%
)
11
8
(3
1.
1%
)
8
(8
%
)
54
(9
.5
%
)
Fa
il
+
re
fe
r
to
di
ag
no
st
ic
s
2
(0
.1
%
)
1
(0
.3
%
)
5
(2
6.
3%
)
8
(2
.7
%
)
6
(2
5%
)
1
(1
%
)
6
(1
00
%
)
4
(0
.7
%
)
A.M. Bussé, et al. International Journal of Pediatric Otorhinolaryngology 134 (2020) 110039
6
completed questionnaire at the start of the screening programme. The
questionnaire identified a positive attitude from the screeners towards
the programme. They indicated their belief screening should be pro-
vided to all Albanian citizens. Screeners feel confident and able to
participate in the programme, they were ready to take on extra
screening tasks because they strongly believed in this screening pro-
gramme. They found the training course to be very informative but
would like to have more follow up training.
After 12 months the questionnaire was distributed again and all
twenty-one screeners returned a filled-out questionnaire. The answers
provided by the screeners after one year of screening were similar to the
previous questionnaire in relation to attitudes and general feelings to-
wards hearing screening. After one year, the screeners felt more con-
fident, did not have to spend as much time preparing for screening and
considered screening to be an obvious part of their daily work.
Screeners spent more time on informing the parents about hearing
screening and noticed parents understood the aim of the screening
programme better because of their explanation. The screeners indicated
their interest in expanding their knowledge on hearing and screening.
The questionnaire will be filled out again after 24 months of screening.
4. Discussion
In the first year of implementation of a NHS programme in four
maternity hospitals in urban and rural areas in Albania, both the uptake
by the screeners and the acceptance by the parents for the first screen
was good. Screeners were keen to improve their skills in screening and
considered NHS valuable for Albanian health care. The number of “fail”
outcomes - the test could not be performed or the threshold was not
reached - on the first screen was high in the beginning but decreased to
less than 10% after eight months. Devices and probes initially broke
often. However, after a “fail” outcome of the first screen, a high number
of infants did not attend the second (32.4%) and third (34.4%) screen,
thereby forming the most important obstacle for implementation of
NHS in Albania. Possible reasons for not attending the second screen
were: not enough information given to parents, administrative pro-
blems such as incorrect contact information and the parents could not
be reminded of repeat screening, follow up examination took place at
another location, the health condition of the infant, parents assumed
their infant could hear, travel distances, time between rescreens and
costs.
The first screen had high acceptance (94.9%), comparable to ac-
ceptance rates in Turkey [6], Italy [41], Poland [42] and Greece [43].
However, 32.4% of infants with a “fail” outcome in the first screen did
not attend the second screen for all four maternity hospitals. Non-at-
tendance was especially high in the MG maternity hospital in Tirana
and in the maternity hospital in Kukës. For all maternity hospitals to-
gether, 34.4% of the infants with a “fail” outcome in the second screen
did not attend the third screen. In retrospect, planning all screening
steps before discharge, reducing the time between screening steps or
choosing a protocol with fewer steps may have prevented these high
non-attendance rates.
The aABR-aABR protocol in Kukës resulted in a lower proportion of
“fail” outcomes compared to Pogradec, similarly rural but less moun-
tainous and more affluent. This may indicate that the use of a two-step
aABR protocol has a higher specificity and reduces the number of “fail”
outcomes. The proportion of infants that did not attend the second
screen was, however, similar to results found in the other maternity
hospitals. The advantage of better specificity for aABR screening may
be offset by larger travel times in mountainous areas.
High non-attendance rate were previously found in newly im-
plemented NHS programmes in Italy (29.9% for the second screen)
[44], Nigeria (43.1% for the second screen) [45] in Turkey (30%) [46]
and in Shanghai (34.32% for the second screen) [11]. Other newly
Fig. 3. The number of infants screened is depicted for the first, second and third screen in the four maternity hospitals in Albania.
The figure shows the number of “Pass” and “Fail” results per screen, the number of infants referred for full diagnostic assessment and the number of infants who did
not attend follow up screening. \‘MG’: Mbretëresha Geraldine, maternity hospital in Tirana; ‘KG’: Koço Gliozheni, maternity hospital in Tirana; ‘OAE’: number of
infants screened with OAE; ‘aABR’: number of infants screened with aABR; ‘unknown’: infants for whom no results were recorded in the database; “Pass”: infants who
reached threshold on the screening test; “Fail”: infants for whom the test could not be performed or the threshold could not be reached; ‘Refer to diagnostics’; refer for
diagnostic assessment in Tirana; ‘Did not attend’: Infants who did not participate in screening due to various reasons.
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implemented NHS programmes have reported non-attendance rates
that are much lower as for example 0.2–0.4% in France [2,7] 4.23% in
Iran [10] and 6% in the Netherlands [12]. Three studies previously
reported that non-attendance reduced when experience in screening
was gained. In Greece non-attendance reduced from 72.2% to 58.2%
after three years of screening. In Colorado 52% of infants did not attend
repeat screening between 1992 and 1996 compared to 24% in 1999
[43,47]. More recently, a non-attendance rate of 19% was reported for
infants born in Colorado in 2005 and 18% for WB born between 2007
and 2012 [48]. Similar rates of non-attendance have been reported for
referral to diagnostic assessment. During the early phase of the UK
implementation the target of diagnostics within four weeks of screen
completing was not met in 60% of cases. However, after seven years
this improved to 17.5% [4].
Acceptance is usually high when the first screen is performed in the
maternity hospital before discharge. In contrast to the first screen, at-
tendance to repeat screens may be much lower when parents have to
overcome practical problems such as larger travel distances and costs
[3,11,12,25,46]. Other reasons for non-attendance described in pre-
vious research were also similar to reasons given by parents and
screeners in Albania: parents did not understand the importance of
screening [49], negative attitudes and lack of awareness in parents or
screeners [25,43], programme organisation [43], cultural reasons [26]
and type of health insurance [50]. Another possible explanation may be
that parents did not receive an invitation for repeat screening after their
infant received a “fail” outcome or that the health condition of the
infant did not allow for screening to be performed yet. In the Nether-
lands, attendance was found to be higher when NHS was combined with
other health care measures thereby also improving the cost-effective-
ness of NHS [12]. In developing countries mothers often do not give
birth in regular maternity hospitals [45], and screening in combination
with other mother or infant health care services has proven to be more
efficient in these countries [45,51]. Similarly, when NHS is organised
within an existing maternal and infant health programme and the
professionals involved are more successful in explaining the importance
to the parents, the number of infants not attending is reduced [2]. To
further reduce the number of non-attendants in Albania, the number of
screening steps may be reduced or repeat screening may be combined
with existing maternal or infant health care services such as vaccina-
tion. When NHS will be implemented in the whole of Albania, multiple
screening locations will be set up across the country so parents do not
have to travel as far.
In previous implementation studies results indicated that parental
awareness is very important to increase the acceptance of screening
[36,37,45,52]. Therefore, the local study coordinator (BQ) developed
leaflets and informative videos that were played in hospital waiting
rooms to inform parents. Furthermore, she appeared in several national
television and radio shows to explain the importance of NHS. The ef-
forts made to inform parents improved their willingness to participate.
The number of “fail” test results in Albania was high initially. This
may have been caused by the early timing of screening or the in-
experience in screeners. As is described by Berninger and Westling
(2011) [30], amniotic fluid that is present in the neonates’middle ear in
the first days of life may cause increased failure rates when performing
OAE screening before the third post-natal day. Despite the fact that a
more optimal timing for the first screen may be five days after birth
[30], most NHS programmes perform the first screen in the maternity
hospital before discharge because high attendance can be achieved. A
number of experienced screening programmes (in the UK, USA and
Italy) have reported low repeat rates despite screening within 48 h after
birth [4,41,42]. Lack of experience with screening may have con-
tributed to high screening repeat rates in Albania, in areas with low
birth numbers like Pogradec and Kukës in particular.
Out of 10,925 infants that participated in the first screen, 411
(3.8%) did not complete screening and for 486, no results were regis-
tered. This may be an issue with database records not being completed.
The proportion of infants that did not reach screen completion was
4.8% in MG, 2.1% in KG, 5.3% in Pogradec and 2.8% in Kukës. Only 33
infants of the 10,925 who started screening were referred for a full
diagnostic assessment. The outcomes of the screening programme show
that more than 95% of eligible infants were covered and less than 4% of
infants were referred, according to the JCIH recommendations. Low
referral rates to full diagnostic assessment may be associated with a
high number of false positives (for example due to multiple screens
within one step), high numbers of infants lost to follow up and high-
quality screening resulting in very low repeat rates between steps. The
referral rates for each screener revealed that a number of screeners did
not refer any infants. Screeners may choose to repeat screening within
one step to be able to give good news to the infants’ parents. This is an
issue that may be addressed in further trainig. Both the high number of
infants that did not reach screen completion and the low number of
infants referred to diagnostic assessment remain areas of concern. These
issues will be followed up in the second year of screening. Low referral
rates to diagnostic assessment were previously found in Turkey (0.01%)
[6], France (0.2%) [7] and China (0.8%) [3]. The number of infants lost
to follow up varied between studies: Caluraud et al. (2015) [7] reported
0.2% for both screening steps while 10% was reported for the same
number of steps by Chen et al. (2017) [3]. Infants lost to follow up were
not reported by Bolat et al. [6]. Another difference found was the
protocol used in these studies. In the study performed by Caluraud et al.
(2015) [7], aABR is used in the first step, Bolat et al. [6] uses aABR only
in the second step and Chen et al. (2017) [3] does not use aABR in any
of the screening steps.
Based on what we have learned from the first year of implementa-
tion, both the successes and the continuing challenges, an im-
plementation plan is being developed to extend NHS to the whole
country. This plan will take into account the areas in which the pro-
gramme is still experiencing difficulties. It will combine current ex-
periences with the experiences from previous implementation, that still
need to be addressed such as the number of infants that do not complete
screening.
In a country where previous implementations of NHS were not
continued because NHS was not considered a priority at that time,
significant successes were achieved in the number of infants reached in
the first screen, improving the awareness in parents and developing a
care pathway. However, the number of infants that do not attend repeat
screening and consequently, the number of infants that does not com-
plete screening remains too high. This issue will be further explored and
addressed in the second year of screening and in the plan for nation-
wide implementation. Additionally, information gathered during this
implementation study will be fed back into the model to improve its
prediction for a nationwide NHS programme in Albania.
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